๐ฐ Client Alert News
Client Alert News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Client Alert. Real-time updates on events, politics, business and more.
May 29, 2024
On May 23, 2024, the California Senate passed a bill that, if approved by the California Assembly before August 31, 2024, and signed into law by Gov. Gavin Newsom, would require U.S. and foreign entities...
May 28, 2024
The Consumer Financial Protection Bureau (CFPB) took action to ensure consumers can dispute charges and obtain refunds on buy now, pay later (BNPL) loans...
May 28, 2024
On May 23, 2024, the California Senate passed a bill that, if approved by the California Assembly before August 31, 2024, and signed into law by Gov. Gavin Newsom, would require U.S....
May 23, 2024
As a reminder, the Securities and Exchange Commission (SEC) and the National Association of Private Fund Managers (NAPFM) and the other Petitioners in the Private Funds Rules Litigation...
May 22, 2024
On May 13, the Securities and Exchange Commission (SEC) and the U.S. Department of the Treasury's Financial Crimes Enforcement Network (FinCEN) released a joint notice of a proposed...
May 22, 2024
As a reminder, the Securities and Exchange Commission (SEC) and the National Association of Private Fund Managers (NAPFM) and the other Petitioners in the Private Funds Rules...
May 6, 2024
On April 23, 2024, the FTC voted to adopt a rule prohibiting employers from entering into non-competes with workers employed by companies over which the FTC...
May 3, 2024
On March 26, 2024, a decree was published in the Mexican Federal Official Gazette amending, adding, and repealing certain provisions of the General Law on Negotiable Instruments and...
May 1, 2024
On April 29, 2024, the Food and Drug Administration (โFDAโ or โthe Agencyโ) released a pre-publication version of the highly anticipated laboratory developed test final rule (โLDT Final...
April 30, 2024
As reported in an earlier Client Alert, on November 7, 2023, the Federal Trade Commission challenged 100 patents as improperly listed in the Food and Drug Administration's "Approved Drug Products...